Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Infection|January 7, 2000
Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study. Swiss HIV Cohort StudyP Sudre, G E Pfyffer, T Bodmer, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
HIV Medicine|February 26, 2015
Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA C Achhra, A Mocroft, M J Ross, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
JAMA|December 22, 1999
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort StudyB Ledergerber, M Egger, V Erard, et al.
HIV Medicine|March 25, 2018
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with menK Aebi-Popp, G Wandeler, L Salazar-Vizcaya, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2019
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort studyL Boschung-Pasquier, A Atkinson, L K Kastner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
HIV Medicine|November 10, 2015
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive personsL Ryom, C Boesecke, V Gisler, et al.
Lancet (London, England)|December 16, 2000
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyG Greub, B Ledergerber, M Battegay, et al.
Pageof 15